PLX PHARMA INC. : Results of Operations and Financial Condition, Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)

Item 2.02 Results of Operations and Financial Condition.

On November 10, 2022, PLx Pharma, Inc. (the "Company") issued a press release announcing its financial results for its third quarter ended September 30, 2022. The Company's press release is attached hereto as Exhibit 99.1.

The information furnished by the Company pursuant to this Item 2.02, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, and shall not be deemed to be incorporated by reference into any Company filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors;

           Appointment of Certain Officers; Compensatory Arrangements of Certain
           Officers.

On November 8, 2022, Anthony Bartsh, a member of the Board of Directors of the Company (the "Board") appointed by the Series A Preferred Stock holders, resigned from the Board, effective immediately after the completion of the Company's 2022 annual meeting of stockholders (the "Annual Meeting"), which was held on November 8, 2022. Mr. Bartsh's resignation is not the result of any disagreement with the Company.

Item 5.07 Submission of Matters to a Vote of Security Holders.

On November 8, 2022, the Company held its Annual Meeting. At the Annual Meeting, the Company's stockholders were asked to vote upon the following:

1. The election of each of Gary Balkema, Kirk Calhoun, Robert Casale, John Hadden

    II, Michael Valentino and Natasha Giordano to serve as directors until the
    Company's 2023 annual meeting of stockholders and until their successors are
    duly elected and qualify;

2. The approval of an advisory vote on the compensation of our named executive

officers as disclosed in the proxy statement; and

3. The ratification of the appointment of Marcum LLP as the Company's independent

    registered public accounting firm for the fiscal year ending December 31,
    2022.

The results of the matters voted on at the Annual Meeting, based on the presence in person or by proxy of holders of record of 19,852,946 of the 29,137,692 shares of the Company's common stock entitled to vote, were as follows:

1. The election of each of Gary Balkema, Kirk Calhoun, Robert Casale, John Hadden

    II, Michael Valentino and Natasha Giordano to serve as directors until the
    Company's 2023 annual meeting of stockholders and until their successors are
    duly elected and qualify was approved as follows:



                         For         Withheld      Broker Non-Votes
Gary Balkema          7,691,361       984,771          11,176,814
Kirk Calhoun          7,800,810       875,322          11,176,814
Robert Casale         7,814,421       861,711          11,176,814
John Hadden II        7,829,325       846,807          11,176,814
Michael Valentino     8,019,932       656,200          11,176,814
Natasha Giordano      7,910,002       766,130          11,176,814

2. The approval of an advisory vote on the compensation of our named executive

officers as disclosed in the proxy statement. The voting results were as

    follows:



     For           Against        Abstain      Broker Non-Votes
  5,688,936       2,880,295       106,901          11,176,814

3. The stockholders ratified the appointment of Marcum LLP as the Company's

independent registered public accounting firm for the fiscal year ending

December 31, 2022. The voting results were as follows:

     For           Against       Abstain      Broker Non-Votes
  19,286,848       344,660       221,438             -

Item 9.01 Financial Statements and Exhibits.

(d)     Exhibits



     Exhibit No.         Description

     99.1                  Press Release, dated November 10, 2022.

     104                 Cover Page Interactive Data File (the cover page
                         XBRL tags are embedded within the Inline XBRL
                         document).

© Edgar Online, source Glimpses